In the present study, we thus aimed to examine whether Rho-kinase inhibition improves high-fat diet (HFD)-induced metabolic disorders in mice, and if so, to elucidate the involvement of AMPK pathway. The gene discussed is PRKAA2; the disease is Other metabolic disease.